Market Cap 1.17B
Revenue (ttm) 42.73M
Net Income (ttm) -204.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -478.31%
Debt to Equity Ratio 0.00
Volume 4,553,224
Avg Vol 2,915,306
Day's Range N/A - N/A
Shares Out 197.05M
Stochastic %K 84%
Beta -1.26
Analysts Strong Sell
Price Target $20.81

Company Profile

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of...

Industry: Biotechnology
Sector: Healthcare
Phone: 65 6236 3388
Address:
Marina One East Tower, 7 Straits View No.12-00, Singapore, Singapore
PepCF
PepCF Aug. 19 at 3:44 PM
$WVE Looking at the upcoming FDA meeting for WVE-006 and the type of people Wave is hiring right now (especially in manufacturing, process validation, and medical affairs), . These are signs that the company is preparing for possible success rather than just running trials. It’s not a guarantee, but the overall picture looks reasonably
0 · Reply
PepCF
PepCF Aug. 19 at 3:25 PM
$WVE Is it a disappointment what this stock has done since the purchase by RA Capital. Comparing it to the last 5 companies they've bought into, it's the only one without a turnaround to date. The late-summer catalysts aren't far off, so either we continue with this garbage trend or there's a real turnaround coming. And I imagine that people who are smarter than me, who have spent between $150M and $170M on this company, did so because they want to make some money on it.
0 · Reply
Valueforall
Valueforall Aug. 19 at 3:06 PM
$WVE Did the algos see I wanted $5.3x? 😑
1 · Reply
Valueforall
Valueforall Aug. 19 at 2:39 PM
$WVE Bring this to the $5.3x’s and I will continue to add! 🙏
0 · Reply
Valueforall
Valueforall Aug. 19 at 2:06 PM
$WVE Hmmm. Did our invitation get lost in the mail? Are we not invited to the party 🎉? 😂
0 · Reply
ThePoorMillionaire
ThePoorMillionaire Aug. 19 at 2:32 AM
$WVE seems like a reversal and the start of a bull trend over 50day. lets go!!!
0 · Reply
balaryan
balaryan Aug. 19 at 1:04 AM
$WVE 1st price target $7.5. Mark this post
0 · Reply
Valueforall
Valueforall Aug. 18 at 7:50 PM
$BCRX I feel for @Fergus20 so gonna share some light hearted stuff $WVE I had this cool pal at a previous company named Nitin a total tech geek turned trader. He was an introverted, quiet nerd and a gentle soul. Soft-spoken and kept his head down, you’d never expect him to make a scene. However, there was something about buying good stocks cheap and beaten down that would bring out this wild and crazy side in him. When he bought a stock he felt was murdered for no good reason, the quiet tech guy vanished. He would put Panjabi MC on the speakers, jump out of his chair, and start full-on dancing and singing right on the floor with both his pointer fingers dangling in the air. ‘While some mudderphuckers are buying the dip, other mudderphuckers are sucking their (you know what)’ It was hilarious 😂. He passed away due to cancer but was able to leave his loved one and little daughter a nice cushion to live off of. I miss him. This moment reminds me of that
2 · Reply
Valueforall
Valueforall Aug. 18 at 7:43 PM
$WVE I had this cool pal at a previous company named Nitin a total tech geek turned trader. He was an introverted, quiet nerd and a gentle soul. Soft-spoken and kept his head down, you’d never expect him to make a scene. However, there was something about buying good stocks cheap and beaten down that would bring out this wild and crazy side in him. When he bought a stock he felt was murdered for no good reason, the quiet tech guy vanished. He would put Panjabi MC on the speakers, jump out of his chair, and start full-on dancing and singing right on the floor with both his pointer fingers dangling in the air. "While some mudderphuckers are buying the dip, other mudderphuckers are sucking their (you know what)." It was hilarious 😂. He passed away due to cancer but was able to leave his loved one and little daughter a nice cushion to live off of. I miss him. This moment reminds me of that and I almost tried to do a dance in his honor.
0 · Reply
Valueforall
Valueforall Aug. 18 at 6:18 PM
$WVE I still love you 😘 when you suck!
0 · Reply
Latest News on WVE
Wave Life Sciences Earnings Call Transcript: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Wave Life Sciences Earnings Call Transcript: Q2 2026


Wave Life Sciences Earnings release: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Wave Life Sciences Earnings release: Q2 2026


Wave Life Sciences Quarterly report: Q2 2026

Jul 30, 2026, 8:30 AM EDT - 20 days ago

Wave Life Sciences Quarterly report: Q2 2026


Wave Life Sciences reports Q2 EPS (34c), consensus (30c)

2026-07-30T11:45:26.000Z - 20 days ago

Wave Life Sciences reports Q2 EPS (34c), consensus (30c)


Wave Life Sciences initiates multidose portion of Inlight trial

2026-06-24T13:05:39.000Z - 2 months ago

Wave Life Sciences initiates multidose portion of Inlight trial


Wave Life Sciences Transcript: Study update

May 18, 2026, 5:30 PM EDT - 3 months ago

Wave Life Sciences Transcript: Study update


Wave Life Sciences Press release: Study update

May 18, 2026, 5:30 PM EDT - 3 months ago

Wave Life Sciences Press release: Study update


Wave Life Sciences Slides: Study update

May 18, 2026, 5:30 PM EDT - 3 months ago

Wave Life Sciences Slides: Study update


Wave Life Sciences Proxy statement: Proxy filing

May 7, 2026, 8:00 AM EDT - 3 months ago

Wave Life Sciences Proxy statement: Proxy filing


Wave Life Sciences price target lowered to $24 from $30 at Citi

2026-05-04T11:00:31.000Z - 3 months ago

Wave Life Sciences price target lowered to $24 from $30 at Citi


Wave Life Sciences Proxy statement: Proxy filing

May 1, 2026, 8:00 AM EDT - 3 months ago

Wave Life Sciences Proxy statement: Proxy filing


Wave Life Sciences Earnings Call Transcript: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Wave Life Sciences Earnings Call Transcript: Q1 2026


Wave Life Sciences Earnings release: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Wave Life Sciences Earnings release: Q1 2026


Wave Life Sciences Quarterly report: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Wave Life Sciences Quarterly report: Q1 2026


Wave Life Sciences Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Wave Life Sciences Proxy statement: Proxy filing


Wave Life Sciences Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 4 months ago

Wave Life Sciences Proxy statement: Proxy filing


Wave Life Sciences Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 4 months ago

Wave Life Sciences Proxy statement: Proxy filing


Wave Life Sciences Transcript: Study result

Mar 26, 2026, 8:30 AM EDT - 5 months ago

Wave Life Sciences Transcript: Study result


Wave Life Sciences Press release: Study result

Mar 26, 2026, 8:30 AM EDT - 5 months ago

Wave Life Sciences Press release: Study result


Wave Life Sciences Slides: Study result

Mar 26, 2026, 8:30 AM EDT - 5 months ago

Wave Life Sciences Slides: Study result


Wave Life Sciences Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Wave Life Sciences Earnings Call Transcript: Q4 2025


Wave Life Sciences Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Wave Life Sciences Annual report: Q4 2025


Wave Life Sciences Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Wave Life Sciences Earnings release: Q4 2025


Why Did Wave Life Sciences Surge 147%?

Dec 15, 2025, 6:30 AM EST - 8 months ago

Why Did Wave Life Sciences Surge 147%?


Wave Life Sciences Transcript: Study Update

Dec 8, 2025, 8:30 AM EST - 9 months ago

Wave Life Sciences Transcript: Study Update


Wave Life Sciences Press release: Study Update

Dec 8, 2025, 8:30 AM EST - 9 months ago

Wave Life Sciences Press release: Study Update


Wave Life Sciences Slides: Study Update

Dec 8, 2025, 8:30 AM EST - 9 months ago

Wave Life Sciences Slides: Study Update


Wave Life Sciences Earnings Call Transcript: Q3 2025

Nov 10, 2025, 8:30 AM EST - 10 months ago

Wave Life Sciences Earnings Call Transcript: Q3 2025


Wave Life Sciences Quarterly report: Q3 2025

Nov 10, 2025, 8:30 AM EST - 10 months ago

Wave Life Sciences Quarterly report: Q3 2025


Wave Life Sciences Earnings release: Q3 2025

Nov 10, 2025, 8:30 AM EST - 10 months ago

Wave Life Sciences Earnings release: Q3 2025


Wave Life Sciences Transcript: Research Day

Oct 29, 2025, 10:00 AM EDT - 10 months ago

Wave Life Sciences Transcript: Research Day


Wave Life Sciences Press release: Research Day

Oct 29, 2025, 10:00 AM EDT - 10 months ago

Wave Life Sciences Press release: Research Day


Wave Life Sciences Slides: Research Day

Oct 29, 2025, 10:00 AM EDT - 10 months ago

Wave Life Sciences Slides: Research Day


Wave Life Sciences Transcript: Status Update

Sep 3, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Transcript: Status Update


Wave Life Sciences Press release: Status Update

Sep 3, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Press release: Status Update


Wave Life Sciences Slides: Status Update

Sep 3, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Slides: Status Update


Wave Life Sciences Earnings Call Transcript: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Earnings Call Transcript: Q2 2025


Wave Life Sciences Quarterly report: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Quarterly report: Q2 2025


Wave Life Sciences Earnings release: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Earnings release: Q2 2025


Wave Life Sciences Proxy statement: Proxy Filing

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Wave Life Sciences Proxy statement: Proxy Filing


Wave Life Sciences Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Earnings Call Transcript: Q1 2025


Wave Life Sciences Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Quarterly report: Q1 2025


Wave Life Sciences Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Earnings release: Q1 2025


Wave Life Sciences Slides: Corporate presentation

May 8, 2025, 7:00 AM EDT - 1 year ago

Wave Life Sciences Slides: Corporate presentation


Wave Life Sciences Transcript: Study Result

Mar 26, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Transcript: Study Result


Wave Life Sciences Press release: Study Result

Mar 26, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Press release: Study Result


Wave Life Sciences Slides: Study Result

Mar 26, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Slides: Study Result


Wave Life Sciences Earnings Call Transcript: Q4 2024

Mar 4, 2025, 8:30 AM EST - 1 year ago

Wave Life Sciences Earnings Call Transcript: Q4 2024


Wave Life Sciences Annual report: Q4 2024

Mar 4, 2025, 8:30 AM EST - 1 year ago

Wave Life Sciences Annual report: Q4 2024


Wave Life Sciences Earnings release: Q4 2024

Mar 4, 2025, 8:30 AM EST - 1 year ago

Wave Life Sciences Earnings release: Q4 2024


PepCF
PepCF Aug. 19 at 3:44 PM
$WVE Looking at the upcoming FDA meeting for WVE-006 and the type of people Wave is hiring right now (especially in manufacturing, process validation, and medical affairs), . These are signs that the company is preparing for possible success rather than just running trials. It’s not a guarantee, but the overall picture looks reasonably
0 · Reply
PepCF
PepCF Aug. 19 at 3:25 PM
$WVE Is it a disappointment what this stock has done since the purchase by RA Capital. Comparing it to the last 5 companies they've bought into, it's the only one without a turnaround to date. The late-summer catalysts aren't far off, so either we continue with this garbage trend or there's a real turnaround coming. And I imagine that people who are smarter than me, who have spent between $150M and $170M on this company, did so because they want to make some money on it.
0 · Reply
Valueforall
Valueforall Aug. 19 at 3:06 PM
$WVE Did the algos see I wanted $5.3x? 😑
1 · Reply
Valueforall
Valueforall Aug. 19 at 2:39 PM
$WVE Bring this to the $5.3x’s and I will continue to add! 🙏
0 · Reply
Valueforall
Valueforall Aug. 19 at 2:06 PM
$WVE Hmmm. Did our invitation get lost in the mail? Are we not invited to the party 🎉? 😂
0 · Reply
ThePoorMillionaire
ThePoorMillionaire Aug. 19 at 2:32 AM
$WVE seems like a reversal and the start of a bull trend over 50day. lets go!!!
0 · Reply
balaryan
balaryan Aug. 19 at 1:04 AM
$WVE 1st price target $7.5. Mark this post
0 · Reply
Valueforall
Valueforall Aug. 18 at 7:50 PM
$BCRX I feel for @Fergus20 so gonna share some light hearted stuff $WVE I had this cool pal at a previous company named Nitin a total tech geek turned trader. He was an introverted, quiet nerd and a gentle soul. Soft-spoken and kept his head down, you’d never expect him to make a scene. However, there was something about buying good stocks cheap and beaten down that would bring out this wild and crazy side in him. When he bought a stock he felt was murdered for no good reason, the quiet tech guy vanished. He would put Panjabi MC on the speakers, jump out of his chair, and start full-on dancing and singing right on the floor with both his pointer fingers dangling in the air. ‘While some mudderphuckers are buying the dip, other mudderphuckers are sucking their (you know what)’ It was hilarious 😂. He passed away due to cancer but was able to leave his loved one and little daughter a nice cushion to live off of. I miss him. This moment reminds me of that
2 · Reply
Valueforall
Valueforall Aug. 18 at 7:43 PM
$WVE I had this cool pal at a previous company named Nitin a total tech geek turned trader. He was an introverted, quiet nerd and a gentle soul. Soft-spoken and kept his head down, you’d never expect him to make a scene. However, there was something about buying good stocks cheap and beaten down that would bring out this wild and crazy side in him. When he bought a stock he felt was murdered for no good reason, the quiet tech guy vanished. He would put Panjabi MC on the speakers, jump out of his chair, and start full-on dancing and singing right on the floor with both his pointer fingers dangling in the air. "While some mudderphuckers are buying the dip, other mudderphuckers are sucking their (you know what)." It was hilarious 😂. He passed away due to cancer but was able to leave his loved one and little daughter a nice cushion to live off of. I miss him. This moment reminds me of that and I almost tried to do a dance in his honor.
0 · Reply
Valueforall
Valueforall Aug. 18 at 6:18 PM
$WVE I still love you 😘 when you suck!
0 · Reply
Valueforall
Valueforall Aug. 18 at 7:51 AM
$WVE Still on track. I step back, 2 steps forward. Means we have more work to do the rest of this week. Possible mms want to break support and wipe any SLs by bringing this to the 4’s for one last dip before the rip. 👌
0 · Reply
JFais
JFais Aug. 17 at 8:58 PM
$WVE (NP) On my DD list to revisit & pretty hated down here INHBE assumed DOA, but making progress with GLP-1 combo and post-incretin maintenance arms of phase 1 INLIGHT study Also, for AATD requested meeting with the FDA for potential AA (end of summer) @WassimLaroussi3
0 · Reply
ThePoorMillionaire
ThePoorMillionaire Aug. 17 at 3:12 PM
$WVE loading so hard here
1 · Reply
PanP
PanP Aug. 17 at 2:46 PM
$WVE Its easy to see where my loses come from, as its the only turd in my portfolio!
0 · Reply
PanP
PanP Aug. 17 at 2:45 PM
$WVE Here it goes again! Ugh
1 · Reply
Valueforall
Valueforall Aug. 17 at 2:25 PM
$WVE Take this to the 4’s. I dare you 😉
0 · Reply
Valueforall
Valueforall Aug. 17 at 4:56 AM
$WVE research suggests 72 hours to weeks for the paperwork to settle when incorporating to Delaware from a foreign entity Let’s see what this week brings. Predictions are meant to be wrong but let’s just say we get back the fake drop from $6 and get $.50 on top closing the week @ $6.5. We struck the lottery if we touch $7. Someone keep me honest by week’s end 🫵
0 · Reply
Valueforall
Valueforall Aug. 17 at 12:23 AM
$WVE When I bought this from $8 all the way down to $6 , $5 was the last thing I expected. But I have trained my brain that all the dips purchased from $6 and below will amplify my ultimate gains. These are shares I would have hesitated buying years ago. Now I smile 😊 at it with conviction. Everyone out there is experiencing their own wave like price action experience. Buy that f’ing dip!
1 · Reply
Valueforall
Valueforall Aug. 16 at 6:58 PM
$WVE Wall Street is pricing Wave Life Sciences near its ~$490M cash runway while treating its proprietary PRISM platform like a zero. They are completely ignoring first-in-class clinical RNA editing in AATD (⁠WVE-006⁠), once-or-twice-yearly dosing for fat loss without muscle wasting in obesity (⁠WVE-007⁠), and a multi-billion-dollar GSK partnership! When the market realizes you are getting a category-defining RNA editing monopoly for pennies over cash, the re-rate will be violent. 🧬💎 🚫 DO NOT FOLLOW ME. I post for my own science log and balance sheet math, not retail cheerleading. If you want hype, go buy a meme coin.
0 · Reply
Valueforall
Valueforall Aug. 14 at 9:04 PM
$WVE those buying dips and have high averages can consider buying $7 covered calls to add buffer
0 · Reply
Valueforall
Valueforall Aug. 14 at 8:35 PM
$WVE assist to our good friend valuefinder on X 1. The Duchenne Muscular Dystrophy (⁠WVE-N531⁠) Strategy Wave is having ongoing discussions with potential commercial partners who already possess global commercial distribution networks. Because ⁠WVE-N531⁠ is advancing toward potential accelerated approval with strong 53% dystrophin expression data, Wave is seeking a partner with an established commercial footprint in rare disease to handle launch and global distribution. 2. Why ⁠WVE-003⁠ (Huntington's Disease) Just Became a Monopolistic Asset The Roche Blowout: Roche/Ionis terminated their competing non-selective ASO program (tominersen). Non-selective therapies knock down both the toxic mutant huntingtin protein (mHTT) and the healthy wild-type huntingtin protein (wtHTT). The Industry Positioning: As Dr. Bolno noted, with Roche's departure, ⁠WVE-003⁠ represents the only allele-selective, wild-type sparing quarterly therapy in clinical development for Huntington's disease.
0 · Reply
Valueforall
Valueforall Aug. 14 at 4:59 PM
@Pika_Capital would you consider a reentry into $WVE ? Been following you for years and while you can be kinda a punk at least the content you spew is worth reading. Your 2025-6 track record has been stellar and there is only 2 others I track that have matched your bio Roi for the past few years
1 · Reply